What's new

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 9, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Remicade, infliximab, ...

Next Article

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, D...

Related Posts

Call for scientific data for the periodic review of the...

Apr 1, 2025  0

Infectious Diseases Working Party (IDWP) consolidated 3...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0